MHC Class II, Tumour Necrosis Factor Alpha, and Lymphotoxin Alpha Gene Haplotype Associations with Serological Subsets of Systemic Lupus Erythematosus

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2005 Aug 19

PMID 16107511

Citations 12

Authors

N J McHugh

P Owen

B Cox

J Dunphy

K Welsh

Affiliations

Soon will be listed here.

Abstract

Objective: To conduct a case-control study to investigate whether there are independent tumour necrosis factor alpha (TNFalpha) or lymphotoxin alpha (LTalpha) haplotype associations with SLE or with any of the major serological subsets of SLE.

Methods: 157 patients with SLE were genotyped for HLA-DRB1, HLA-DQB1, TNFalpha, and LTalpha alleles by polymerase chain reaction and compared with 245 normal white controls. For TNFalpha, six single nucleotide polymorphisms (SNPs) at positions -1031, -863, -857, -308, -238, and +488 and for LTalpha three SNPs at positions +720, +365, and +249 were studied to assign six TNFalpha haplotypes (TNF1-6) and four LTalpha haplotypes (LTA1-4). All SLE patients had full serological profiles on serial samples.

Results: The most significant association with SLE overall was with HLA-DR3 (p<0.001; odds ratio (OR) = 2.5 (95% confidence interval, 1.6 to 3.8)) and the extended haplotype HLA-DQB1*0201;DRB1*0301;TNF2;LTA2 (p<0.001; OR = 2.3 (1.4 to 3.7)). Associations were strongest in the anti-La positive group (13%) of SLE patients (HLA-DR3, OR = 71 (9 to 539); HLA-DQB1*0201, OR = 35 (5 to 267); TNF2, OR = 10 (2.8 to 36), and LTA2, OR = 4.9 (1.1 to 21)). There was an increase in the HLA-DR2 associated extended haplotype (HLA-DQB1*0602;DRB1*1501;TNF1;LTA1) in patients with anti-Ro in the absence of anti-La (p<0.005; OR = 3.9 (1.5 to 10)). The HLA-DR7 extended haplotype (HLA-DQB1*0303;DRB1*0701/2;TNF5;LTA3) was decreased in SLE overall (p<0.02; OR = 0.2 (0.05 to 0.8)).

Conclusions: The strongest association in this predominantly white population with SLE was between HLA-DR3 and anti-La, which seemed to account for any associations with TNFalpha alleles on an extended DR3 haplotype.

Citing Articles

Host and bacterial factors linking periodontitis and rheumatoid arthritis.

Krutyholowa A, Strzelec K, Dziedzic A, Bereta G, Lazarz-Bartyzel K, Potempa J Front Immunol. 2022; 13:980805.

PMID: 36091038 PMC: 9453162. DOI: 10.3389/fimmu.2022.980805.

Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different?.

Selvaraja M, Too C, Tan L, Koay B, Abdullah M, Shah A Lupus Sci Med. 2022; 9(1).

PMID: 35105721 PMC: 8808435. DOI: 10.1136/lupus-2021-000554.

Association between tumor necrosis factor polymorphisms and rheumatoid arthritis as well as systemic lupus erythematosus: a meta-analysis.

Chen L, Huang Z, Liao Y, Yang B, Zhang J Braz J Med Biol Res. 2019; 52(3):e7927.

PMID: 30916218 PMC: 6437938. DOI: 10.1590/1414-431X20187927.

Association of and Polymorphisms with Risk of Systemic Lupus Erythematosus.

Xue K, Niu W, Cui Y Chin Med J (Engl). 2018; 131(23):2844-2851.

PMID: 30511687 PMC: 6278195. DOI: 10.4103/0366-6999.246058.

Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.

Zhao Z, Ren J, Dai C, Kannapell C, Wang H, Gaskin F Ann Rheum Dis. 2018; 78(3):380-390.

PMID: 30254034 PMC: 6377330. DOI: 10.1136/annrheumdis-2018-214125.

References

Arnett F, Hamilton R, Reveille J, Bias W, Harley J, Reichlin M . Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum. 1989; 32(4):413-9. DOI: 10.1002/anr.1780320410. View

Granados J, Vargas-Alarcon G, Drenkard C, Andrade F, Melin-Aldana H, Alcocer-Varela J . Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus. 1997; 6(1):57-62. DOI: 10.1177/096120339700600108. View

Gordon C, Ranges G, Greenspan J, Wofsy D . Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol. 1989; 52(3):421-34. DOI: 10.1016/0090-1229(89)90157-8. View

Chen C, Yen J, Tsai W, Wu C, Chiang W, Tsai J . The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett. 1997; 55(1):1-3. DOI: 10.1016/s0165-2478(96)02635-1. View

Fanning G, Bunce M, Black C, Welsh K . Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens. 1997; 50(1):23-31. DOI: 10.1111/j.1399-0039.1997.tb02829.x. View

Sullivan K, Wooten C, Schmeckpeper B, Goldman D, Petri M . A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 1998; 40(12):2207-11. DOI: 10.1002/art.1780401215. View

Rischmueller M, Lester S, Chen Z, Champion G, van den Berg R, Beer R . HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol. 1998; 111(2):365-71. PMC: 1904917. DOI: 10.1046/j.1365-2249.1998.00504.x. View

Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, Fukumoto T . Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum. 1998; 41(5):927-34. DOI: 10.1002/1529-0131(199805)41:5<927::AID-ART21>3.0.CO;2-R. View

Reveille J, Moulds J, Ahn C, Friedman A, Baethge B, Roseman J . Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998; 41(7):1161-72. DOI: 10.1002/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K. View

10.

McCluskey J, Farris A, Keech C, Purcell A, Rischmueller M, Kinoshita G . Determinant spreading: lessons from animal models and human disease. Immunol Rev. 1998; 164:209-29. DOI: 10.1111/j.1600-065x.1998.tb01222.x. View

11.

Gladman D, Urowitz M, Darlington G . Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus. 1999; 8(6):466-70. DOI: 10.1177/096120339900800610. View

12.

Lu L, Ding W, Fici D, Deulofeut R, Cheng H, Cheu C . Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum. 1997; 40(6):1138-45. DOI: 10.1002/art.1780400619. View

13.

McHugh N, Maddison P . HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1989; 32(12):1623-4. DOI: 10.1002/anr.1780321222. View

14.

Jacob C, Fronek Z, Lewis G, Koo M, Hansen J, McDevitt H . Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990; 87(3):1233-7. PMC: 53445. DOI: 10.1073/pnas.87.3.1233. View

15.

Fujisaku A, FRANK M, Neas B, Reichlin M, Harley J . HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest. 1990; 86(2):606-11. PMC: 296767. DOI: 10.1172/JCI114751. View

16.

McHugh N, James I, Maddison P . Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. J Rheumatol. 1990; 17(10):1320-8. View

17.

Reveille J, MacLeod M, Whittington K, Arnett F . Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol. 1991; 146(11):3871-6. View

18.

Olerup O, ZETTERQUIST H . HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens. 1991; 37(5):197-204. DOI: 10.1111/j.1399-0039.1991.tb01872.x. View

19.

Hartung K, Ehrfeld H, Lakomek H, Coldewey R, Lang B, Krapf F . The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group. Rheumatol Int. 1992; 11(6):243-9. DOI: 10.1007/BF00301501. View

20.

ZETTERQUIST H, Olerup O . Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol. 1992; 34(1):64-74. DOI: 10.1016/0198-8859(92)90086-3. View